By Jim Datin, President and CEO, BioAgilytix Bioanalytical outsourcing has changed dramatically in the past 30 years, which isn’t surprising when you consider how our economy, the healthcare market, technology, and drugs themselves have changed in that same period. In order … Read More »

October 15-16, 2018 in Washington, D.C. During the 2018 NORD Rare Summit, over 700 leaders from FDA, NIH, industry, patient groups, payers and research institutions will address the New Era of Patient-Focused Innovation. Together, NORD Rare Summit attendees will explore the … Read More »

At the 2018 DIA conference in Boston, Taren Grom, Editor-in-Chief of PharmaVOICE sat down with Peter Benton to discuss the evolution of clinical research and CROs. Some of the topics covered include… The evolution of the CRO industry The sustainability of the current M … Read More »

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part three of a three-part series that discusses how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. Focusing … Read More »

In this blog post, we’ll share some highlights about Bhaskar Sambasivan, and see some of the reasons why he was honored in this year’s PharmaVOICE 100. You can also read his full profile here. He is leading the convergence of life sciences and healthcare. He has made investm … Read More »

In this blog post, we’ll share some highlights about Rami Levin, and see some of the reasons why he was honored in this year’s PharmaVOICE 100. You can also read his full profile here. Since being named president of Sobi North America in 2014, Rami Levin has built the compan … Read More »

Medidata NEXT is an immersive experience that unites 3,000 professionals in Life Sciences across seven global events. At NEXT, you’ll have the opportunity to connect with, learn from and be inspired by an array of industry thought leaders and so much more. Come see what the … Read More »

By Jim Datin, President and CEO, BioAgilytix Finding the right talent is challenging for any organization in any industry, but when you operate in a technical field that requires highly skilled workers, it can be even more difficult. Back in the late 90s during the peak of t … Read More »

Are we closer to finding a cure for MS? Attend this webinar to find out. July 11, 2018 | 10:00am ET Discover insights from the experts at GeNeuro, a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, about the first clini … Read More »

By Jim Datin, President and CEO of BioAgilytix There are a number of factors driving rapid growth of the global biologics market today. For one, pharmaceutical and biotech companies are shifting more investment into the discovery and development of large molecule therapeutic … Read More »

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part two of a three-part series that discusses how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. Our Environ … Read More »

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part one of a three-part series that will discuss how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. A New Un … Read More »

What do you get when Senior Pharmaceutical Executives get together and brainstorm about disruptive innovation in the Life Sciences industry? You get some pretty interesting perspectives, and perhaps even a glimpse into the future. Early in 2018, ICON gathered a group of indu … Read More »

Hundreds of visionaries will be descending on Aspen, Colorado from June 21-24 for the Aspen Ideas Festival: Spotlight Health. This three-day health conference features an exceptional mix of inspiring and provocative experts who dive into the latest topics in medicine, scienc … Read More »

NORD’s 35th Anniversary Celebration presenting the 2018 Rare Impact Awards will be held on May 17, 2018, in Washington, D.C. at the Andrew W. Mellon Auditorium. This event will celebrate the efforts to help the 30 million Americans with rare diseases who, by the very nature … Read More »

Every once in a while a story comes along that grabs you, inspires you, and motivates you. This is one of those stories. A March 26, 2018 article in Forbes provides an in-depth profile of Kathy Giusti, Founder of the Multiple Myeloma Research Foundation (MMRF) and Co-Chair o … Read More »

From drug discovery to clinical practice, a brand journey requires connected thinking. Connected thinking includes these critical skill sets: Identify the KOL landscape – with real segmentation around mindset and behavior Understand the science – with insight and vision Craf … Read More »

The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients and provided incentives to pharmaceutical manufacturers, including tax credits for the costs of clinical research, seven years of patent exclusivity, and the waiv … Read More »

For many, a career in the life-sciences industry means far more than just a paycheck. It’s about advancing medicine, improving lives and patient care, and innovating new ways of addressing challenges. Most people you meet in this industry have a story about why they chose th … Read More »

It’s an exciting, yet challenging time for clinical research. Technology innovations open up a world of data for researchers and the ability to collect it faster. It’s all good news—better accuracy, more data-driven decisions and improved treatment for patients. But there’s … Read More »